INFINITY PHARMACEUTICALS INC's ticker is INFI and the CUSIP is 45665G303. A total of 143 filers reported holding INFINITY PHARMACEUTICALS INC in Q1 2015. The put-call ratio across all filers is 0.80 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2018 | $28,000 | +3.7% | 13,488 | +0.6% | 0.00% | – |
| Q4 2017 | $27,000 | +35.0% | 13,406 | -11.1% | 0.00% | – |
| Q3 2017 | $20,000 | -16.7% | 15,080 | +0.0% | 0.00% | – |
| Q2 2017 | $24,000 | -54.7% | 15,078 | -9.8% | 0.00% | – |
| Q1 2017 | $53,000 | +140.9% | 16,714 | +0.1% | 0.00% | – |
| Q4 2016 | $22,000 | -15.4% | 16,702 | +0.3% | 0.00% | – |
| Q3 2016 | $26,000 | -99.2% | 16,655 | -90.9% | 0.00% | -100.0% |
| Q4 2014 | $3,107,000 | +22.0% | 183,942 | -0.2% | 0.01% | 0.0% |
| Q4 2013 | $2,546,000 | -8.7% | 184,336 | +15.3% | 0.01% | -20.0% |
| Q3 2013 | $2,789,000 | +43.2% | 159,816 | +33.4% | 0.01% | +25.0% |
| Q2 2013 | $1,947,000 | – | 119,809 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 1,100,000 | $14,762,000 | 6.34% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 3,882,805 | $52,107,000 | 1.90% |
| Cheyne Capital Management (UK) LLP | 326,821 | $4,388,000 | 1.56% |
| BB BIOTECH AG | 2,320,737 | $31,144,000 | 1.27% |
| Broadfin Capital, LLC | 854,384 | $11,466,000 | 1.20% |
| HealthCor Management, L.P. | 1,162,200 | $15,597,000 | 0.80% |
| Orbimed Advisors | 4,736,900 | $63,569,000 | 0.66% |
| Rhenman & Partners Asset Management AB | 148,000 | $1,986,000 | 0.58% |
| SOUND ENERGY PARTNERS, INC. | 51,000 | $684,000 | 0.53% |
| Rock Springs Capital Management LP | 210,000 | $2,818,000 | 0.44% |